Innovation Intelligence: Where IP Meets Market Strategy
Lagerman Subsidium offer business development and affordable market analysis services tailored for your life science sector. Leveraging deep expertise in business development and intellectual property, we go beyond traditional market reviews by integrating advanced patent and clinical trial database analysis with cutting-edge artificial intelligence tools. Our insights support product positioning, licensing models, and strategic decision-making to ensure your product avoids risks and succeed in a competitive market.
What Innovation Intelligence services do we offer?
  • Technology & Market Intelligence
    We synthesize both patent and market data to map the technology landscape, profile key market actors, and identify emerging technologies and macrotrends, thereby supporting licensing models, Freedom-to-Operate (FTO) assessments, and early commercialization.
  • Continuous Innovation Surveillance
    We provide ongoing monitoring services to track competitor activities, technology advancements, and market dynamics. Through regular updates on patent filings, product launches, and pipeline developments, we ensure you stay ahead of industry shifts with timely market forecasts and competitor watch reports.
  • Commercialization Roadmapping
    We identify strategic differentiation opportunities by uncovering white-space gaps for innovations. Our roadmaps align your R&D efforts and IP portfolio with market demands, translating insights into concrete next steps that support commercial planning.
  • Funding Application Support
    We strengthen funding applications by integrating IP strategy and business planning into coherent, risk‑aware proposals, with the option for hands‑on support during project implementation once funding is secured. This work can be both full draft proposals or targeted content for specific work packages.
  • Asset Valuations and Licensing
    We quantify the commercial value of your intellectual property assets and develop corresponding licensing strategies. Our customized licensing models and agreement structures streamline negotiations and enable profitable partnerships with well-defined deal terms, including payment structures, cost-sharing arrangements, and IP ownership provisions.
  • Due Diligence Assessment
    We perform thorough evaluations of intellectual property portfolios during mergers, acquisitions, or partnerships. Our assessments highlight potential risks and opportunities, supporting informed decision-making in corporate transactions while reinforcing long-term IP strategy.
  • Freedom-To-Operate Assessments
    We conduct comprehensive evaluation of potential patent risks to ensure your product can be commercialized without infringing on existing intellectual property rights. This includes patent landscape analysis, detailed patent claim evaluations, infringement risk assessments, and strategic mitigation strategies such as design-around solutions and licensing opportunities.
Why Choose Us?
What sets us apart is our ability to combine business development insights with actionable intelligence. We serve as a flexible resource, delivering both customized, in-depth reports and ongoing monitoring of your competitors and market landscape. With deep expertise across biotechnology, pharmaceuticals, medical devices, diagnostics, digital health, and the broader life sciences sector, we bridge the gap between business strategy and intellectual property analysis. We help you make informed decisions to achieve your business goals.
Your main point of contact will be Alexander Lagerman, an IPR expert with over a decade of experience in the life science industry. With an educational background in Bioscience Business, Molecular Biology, and Corporate Economics, Alexander has collaborated with more than 50 life science projects across various sectors including drug development (antibodies, peptides, small molecules, drug delivery systems), advanced therapies (vaccines, viral vector-based therapies, cell therapies, gene‑modified immune cell therapies), medical devices (blood analyte measurement, dry-eye management, dental equipment), diagnostics (biomarkers, genetic testing, cardiovascular diagnostics, PET tracers, imaging technologies), platform technologies (lab‑on‑chip systems, biosensors, assays, droplet‑based and other microfluidic technologies), lab tools & consumables (reagents & labels, disease models, 3D cell cultures, extracellular vesicle isolation), bioprocessing & manufacturing (cell line engineering, purification processes), R&D services (ADME studies, immunogenicity assessments).
How to Contact Us?
Please feel free to contact us today for a consultation and discover how we can support your innovation intelligence.
Оur contacts:

© All Right Reserved. Lagerman Subsidium
Made on
Tilda